{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:24:22Z","timestamp":1794666262299,"version":"4.9.1"},"reference-count":125,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T00:00:00Z","timestamp":1703376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Chronic thromboembolic pulmonary disease results from the incomplete resolution of thrombi, leading to fibrotic obstructions. These vascular obstructions and additional microvasculopathy may lead to chronic thromboembolic pulmonary hypertension (CTEPH) with increased pulmonary arterial pressure and pulmonary vascular resistance, which, if left untreated, can lead to right heart failure and death. The pathobiology of CTEPH has been challenging to unravel due to its rarity, possible interference of results with anticoagulation, difficulty in selecting the most relevant study time point in relation to presentation with acute pulmonary embolism (PE), and lack of animal models. In this article, we review the most relevant multifaceted cross-talking pathogenic mechanisms and advances in understanding the pathobiology in CTEPH, as well as its challenges and future direction. There appears to be a genetic background affecting the relevant pathological pathways. This includes genetic associations with dysfibrinogenemia resulting in fibrinolysis resistance, defective angiogenesis affecting thrombus resolution, and inflammatory mediators driving chronic inflammation in CTEPH. However, these are not necessarily specific to CTEPH and some of the pathways are also described in acute PE or deep vein thrombosis. In addition, there is a complex interplay between angiogenic and inflammatory mediators driving thrombus non-resolution, endothelial dysfunction, and vascular remodeling. Furthermore, there are data to suggest that infection, the microbiome, circulating microparticles, and the plasma metabolome are contributing to the pathobiology of CTEPH.<\/jats:p>","DOI":"10.3390\/biomedicines12010046","type":"journal-article","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T20:48:37Z","timestamp":1703450917000},"page":"46","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-3355","authenticated-orcid":false,"given":"Hakim","family":"Ghani","sequence":"first","affiliation":[{"name":"Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge CB2 0AY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pepke-Zaba","sequence":"additional","affiliation":[{"name":"Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge CB2 0AY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1801915","DOI":"10.1183\/13993003.01915-2018","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"53","author":"Kim","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1513\/AnnalsATS.201509-620AS","article-title":"The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension","volume":"13","author":"Lang","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"160112","DOI":"10.1183\/16000617.0112-2016","article-title":"The pathophysiology of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Simonneau","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.21037\/acs-2021-pte-10","article-title":"Chronic thromboembolic pulmonary hypertension: The magic of pathophysiology","volume":"11","author":"Simonneau","year":"2022","journal-title":"Ann. Cardiothorac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.00169113","article-title":"Microvascular disease in chronic thromboembolic pulmonary hypertension: A role for pulmonary veins and systemic vasculature","volume":"44","author":"Ghigna","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/CIRCULATIONAHA.105.602565","article-title":"Chronic Thromboembolic Pulmonary Hypertension","volume":"113","author":"Hoeper","year":"2006","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic Thromboembolic Pulmonary Hypertension (CTEPH)","volume":"124","author":"Delcroix","year":"2011","journal-title":"Circulation"},{"key":"ref_9","first-page":"1043","article-title":"Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou Heparin Standard: Evaluation dans l\u2019Embolie Pulmonaire Study","volume":"41","author":"Wartski","year":"2000","journal-title":"J. Nucl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejim.2011.08.018","article-title":"Residual pulmonary thromboemboli after acute pulmonary embolism","volume":"23","author":"Herrero","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1513\/AnnalsATS.201509-619AS","article-title":"From Acute to Chronic Thromboembolic Disease","volume":"13","author":"Fernandes","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"160121","DOI":"10.1183\/16000617.0121-2016","article-title":"An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan","volume":"26","author":"Gall","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ruaro, B., Baratella, E., Caforio, G., Confalonieri, P., Wade, B., Marrocchio, C., Geri, P., Pozzan, R., Andrisano, A.G., and Cova, M.A. (2022). Chronic Thromboembolic Pulmonary Hypertension: An Update. Diagnostics, 12.","DOI":"10.3390\/diagnostics12020235"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2300449","DOI":"10.1183\/13993003.00449-2023","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: An updated systematic review and meta-analysis","volume":"62","author":"Luijten","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1183\/09059180.00009111","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"21","author":"Kim","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.00087608","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"33","author":"Bonderman","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1183\/09031936.00101612","article-title":"Chronic thromboembolic pulmonary hypertension: Animal models","volume":"41","author":"Mercier","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e09014","DOI":"10.1016\/j.heliyon.2022.e09014","article-title":"Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension","volume":"8","author":"Karpov","year":"2022","journal-title":"Heliyon"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Perros, F., Ghigna, M.R., Loisel, F., Chemla, D., Decante, B., de Montpreville, V., Montani, D., Humbert, M., Fadel, E., and Mercier, O. (2020). Description, Staging and Quantification of Pulmonary Artery Angiophagy in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension. Biomedicines, 8.","DOI":"10.3390\/biomedicines8110493"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2002828","DOI":"10.1183\/13993003.02828-2020","article-title":"ERS statement on chronic thromboembolic pulmonary hypertension","volume":"57","author":"Delcroix","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.12703\/P6-38","article-title":"Chronic thromboembolic pulmonary hypertension: Time for research in pathophysiology to catch up with developments in treatment","volume":"6","author":"Toshner","year":"2014","journal-title":"F1000Prime Rep."},{"key":"ref_22","first-page":"741","article-title":"Chronic thromboembolic pulmonary hypertension: Initial experience of patients undergoing pulmonary thromboendarterectomy","volume":"40","author":"Jenkins","year":"2021","journal-title":"Rev. Port. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1183\/09031936.00009914","article-title":"Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension","volume":"46","author":"Quarck","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood-2009-03-208264","article-title":"High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension","volume":"114","author":"Morris","year":"2009","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.thromres.2013.09.024","article-title":"Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure","volume":"132","author":"Marsh","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1164\/rccm.200506-916OC","article-title":"Fibrin Derived from Patients with Chronic Thromboembolic Pulmonary Hypertension Is Resistant to Lysis","volume":"173","author":"Morris","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"L979","DOI":"10.1152\/ajplung.90412.2008","article-title":"Chronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca2+ in human pulmonary arterial smooth muscle and endothelial cells","volume":"296","author":"Firth","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_28","unstructured":"Liang, N.C., Firth, A.L., Marsh, J.J., Yuan, J.X., and Morris, T.A. (2011). A106 Chronic Thromboembolic Pulmonary Hypertension: Bench to Bedside, American Thoracic Society."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1034\/j.1399-3003.2000.15b28.x","article-title":"Thrombotic risk factors in pulmonary hypertension","volume":"15","author":"Wolf","year":"2000","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1160\/TH03-02-0067","article-title":"High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension","volume":"90","author":"Bonderman","year":"2003","journal-title":"Thromb. Haemost."},{"key":"ref_31","first-page":"9700","article-title":"Platelet abnormalities in chronic thromboembolic pulmonary hypertension","volume":"8","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1801805","DOI":"10.1183\/13993003.01805-2018","article-title":"The ADAMTS13\u2013VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension","volume":"53","author":"Newnham","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1164\/rccm.202109-2075OC","article-title":"Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension","volume":"205","author":"Manz","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Vrigkou, E., Tsantes, A., Konstantonis, D., Rapti, E., Maratou, E., Pappas, A., Halvatsiotis, P., and Tsangaris, I. (2022). Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051238"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/ATVBAHA.114.304404","article-title":"Platelets Are Highly Activated in Patients of Chronic Thromboembolic Pulmonary Hypertension","volume":"34","author":"Yaoita","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/01.CIR.86.4.1241","article-title":"Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension","volume":"86","author":"Olman","year":"1992","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.CIR.90.2.706","article-title":"Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli","volume":"90","author":"Lang","year":"1994","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/01.CIR.89.6.2715","article-title":"Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli","volume":"89","author":"Lang","year":"1994","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/ATVBAHA.115.306845","article-title":"Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension","volume":"36","author":"Yaoita","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.115.016522","article-title":"Long-Term Outcome of Patients with Chronic Thromboembolic Pulmonary Hypertension","volume":"133","author":"Delcroix","year":"2016","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/CIRCRESAHA.121.318225","article-title":"Inflammation, Infection and Venous Thromboembolism","volume":"128","author":"Colling","year":"2021","journal-title":"Circ. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.healun.2022.08.021","article-title":"Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH\u2014Results from a prospective discovery and validation biomarker study","volume":"42","author":"Hadinnapola","year":"2023","journal-title":"J. Heart Lung Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/rccm.202201-0001ED","article-title":"More Evidence for Inflammatory Thrombosis in Chronic Thromboembolic Pulmonary Hypertension: Is the Embolic Hypothesis Losing Ground?","volume":"205","author":"Sharma","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Smolders, V.F.E.D., Lodder, K., Rodr\u00edguez, C., Tura-Ceide, O., Barber\u00e0, J.A., Jukema, J.W., Quax, P.H.A., Goumans, M.J., and Kurakula, K. (2021). The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression. Cells, 10.","DOI":"10.3390\/cells10040737"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"A84","DOI":"10.1136\/thoraxjnl-2014-206260.166","article-title":"P16 A Systematic Characterisation Of Inflammation in Chronic Thromboembolic Pulmonary Hypertension","volume":"69","author":"Hadinnapola","year":"2014","journal-title":"Thorax"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/ATVBAHA.113.302991","article-title":"Defective Angiogenesis Delays Thrombus Resolution","volume":"34","author":"Alias","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2013-04-499558","article-title":"Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution","volume":"122","author":"Kellermair","year":"2013","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/ATVBAHA.107.151456","article-title":"PECAM-1: A Multi-Functional Molecule in Inflammation and Vascular Biology","volume":"27","author":"Woodfin","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zabini, D., Nagaraj, C., Stacher, E., Lang, I.M., Nierlich, P., Klepetko, W., Heinemann, A., Olschewski, H., B\u00e1lint, Z., and Olschewski, A. (2012). Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043793"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2004196","DOI":"10.1183\/13993003.04196-2020","article-title":"Role of angiopoietin-2 in venous thrombus resolution and chronic thromboembolic disease","volume":"58","author":"Hobohm","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-\u03b1 and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1378\/chest.126.1.135","article-title":"Cytokine Response to Pulmonary Thromboendarterectomy","volume":"126","author":"Langer","year":"2004","journal-title":"Chest"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","article-title":"Neutrophil Extracellular Traps Promote Angiogenesis","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.2020005861","article-title":"Neutrophil extracellular traps promote fibrous vascular occlusions in chronic thrombosis","volume":"137","author":"Sharma","year":"2021","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: Tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9254087","DOI":"10.1155\/2020\/9254087","article-title":"Neutrophil Extracellular Traps: Signaling Properties and Disease Relevance","volume":"2020","author":"Li","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jth.12571","article-title":"Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development","volume":"12","author":"Savchenko","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1183\/09031936.00197511","article-title":"Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension","volume":"40","author":"Wynants","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"H1643","DOI":"10.1152\/ajpheart.00938.2008","article-title":"CRP is a novel ligand for the oxidized LDL receptor LOX-1","volume":"296","author":"Shih","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_62","first-page":"127","article-title":"Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-\u03baB signaling","volume":"4","author":"Kanaji","year":"2011","journal-title":"J. Inflamm. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2013-0355OC","article-title":"Nuclear Factor \u03baB Inhibition Reduces Lung Vascular Lumen Obliteration in Severe Pulmonary Hypertension in Rats","volume":"51","author":"Farkas","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"L934","DOI":"10.1152\/ajplung.00034.2013","article-title":"NF-\u03baB pathway is involved in CRP-induced effects on pulmonary arterial endothelial cells in chronic thromboembolic pulmonary hypertension","volume":"305","author":"Wynants","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1183\/09031936.00145013","article-title":"Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients","volume":"44","author":"Zabini","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2016.08.012","article-title":"Abnormal pulmonary endothelial cells may underlie the enigmatic pathogenesis of chronic thromboembolic pulmonary hypertension","volume":"36","author":"Mercier","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2045894019845611","DOI":"10.1177\/2045894019845611","article-title":"Right heart in pulmonary hypertension: From adaptation to failure","volume":"9","author":"Ren","year":"2019","journal-title":"Pulm. Circ."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/cvr\/cvx159","article-title":"Role of cardiac inflammation in right ventricular failure","volume":"113","author":"Sun","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/2045893217714463","article-title":"Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension","volume":"7","author":"Samson","year":"2017","journal-title":"Pulm. Circ."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCHEARTFAILURE.123.010478","article-title":"Distinct Inflammatory Milieu in Patients with Right Heart Failure","volume":"16","author":"Yang","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1160\/TH04-10-0657","article-title":"Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension","volume":"93","author":"Bonderman","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/ATVBAHA.107.156000","article-title":"Role for Staphylococci in Misguided Thrombus Resolution of Chronic Thromboembolic Pulmonary Hypertension","volume":"28","author":"Bonderman","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Chen, Z., Zhang, N., Chu, H.Y., Yu, Y., Zhang, Z.K., Zhang, G., and Zhang, B.T. (2020). Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.593269"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Tie, Y., Tang, F., Peng, D., Zhang, Y., and Shi, H. (2022). TGF-beta signal transduction: Biology, function and therapy for diseases. Mol. Biomed., 3.","DOI":"10.1186\/s43556-022-00109-9"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"s-3","DOI":"10.1089\/sur.2006.7.s2-3","article-title":"Mediator Responses in Surgical Infections","volume":"7","author":"Aasen","year":"2006","journal-title":"Surg. Infect."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"20190","DOI":"10.1074\/jbc.M601956200","article-title":"Staphylococcus aureus Protein A Activates TNFR1 Signaling through Conserved IgG Binding Domains","volume":"281","author":"Magargee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: Mechanistic insights","volume":"71","author":"Tilg","year":"2022","journal-title":"Gut"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.119.14294","article-title":"Altered Gut Microbiome Profile in Patients with Pulmonary Arterial Hypertension","volume":"75","author":"Kim","year":"2020","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Wu, P., Zhu, T., Tan, Z., Chen, S., and Fang, Z. (2022). Role of Gut Microbiota in Pulmonary Arterial Hypertension. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.812303"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","article-title":"Intersections between Microbiome and Heart Failure: Revisiting the Gut Hypothesis","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J. Card. Fail."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Ikubo, Y., Sanada, T.J., Hosomi, K., Park, J., Naito, A., Shoji, H., Misawa, T., Suda, R., Sekine, A., and Sugiura, T. (2022). Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: A single-center observational study in Japan. BMC Pulm. Med., 22.","DOI":"10.1186\/s12890-022-01932-0"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archsurg.1978.01370190030004","article-title":"Thromboembolic risk of postsplenectomy thrombocytosis","volume":"113","author":"Boxer","year":"1978","journal-title":"Arch. Surg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/thx.2004.038083","article-title":"Splenectomy and chronic thromboembolic pulmonary hypertension","volume":"60","author":"Ioos","year":"2005","journal-title":"Thorax"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijsu.2015.10.011","article-title":"Splenectomy is associated with a higher risk for venous thromboembolism: A prospective cohort study","volume":"24","author":"Lee","year":"2015","journal-title":"Int. J. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1538-7836.2010.03849.x","article-title":"Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: A 10-year nationwide cohort study","volume":"8","author":"Thomsen","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1365-2141.2002.03711.x","article-title":"Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E\/\u03b2-thalassaemic patients","volume":"118","author":"Atichartakarn","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e000772","DOI":"10.1161\/JAHA.113.000772","article-title":"Splenectomy Is Modifying the Vascular Remodeling of Thrombosis","volume":"3","author":"Frey","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2045894019890553","DOI":"10.1177\/2045894019890553","article-title":"Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension","volume":"10","author":"Heresi","year":"2020","journal-title":"Pulm. Circ."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2003201","DOI":"10.1183\/13993003.03201-2020","article-title":"Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension","volume":"57","author":"Swietlik","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jbior.2017.09.011","article-title":"The importance of blood platelet lipid signaling in thrombosis and in sepsis","volume":"67","author":"Mujalli","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","article-title":"Metabolic Impairment in Heart Failure","volume":"64","author":"Doehner","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1183\/09031936.00055107","article-title":"Fibrinogen A Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension","volume":"31","author":"Suntharalingam","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Li, J.F., Lin, Y., Yang, Y.H., Gan, H.L., Liang, Y., Liu, J., Yang, S.Q., Zhang, W.J., Cui, N., and Zhao, L. (2013). Fibrinogen A\u03b1 Thr312Ala Polymorphism Specifically Contributes to Chronic Thromboembolic Pulmonary Hypertension by Increasing Fibrin Resistance. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069635"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jth.12221","article-title":"Structure\u2013function and regulation of ADAMTS-13 protease","volume":"11","author":"Zheng","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.blre.2014.04.003","article-title":"Von Willebrand factor and ADAMTS13 in arterial thrombosis: A systematic review and meta-analysis","volume":"28","author":"Sonneveld","year":"2014","journal-title":"Blood Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11239-015-1323-2","article-title":"The role of mononuclear cell tissue factor and inflammatory cytokines in patients with chronic thromboembolic pulmonary hypertension","volume":"42","author":"Yang","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1538-7836.2007.02818.x","article-title":"ABO(H) blood groups and vascular disease: A systematic review and meta-analysis","volume":"6","author":"Wu","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.molcel.2019.12.021","article-title":"Chromosome Conformation Capture and Beyond: Toward an Integrative View of Chromosome Structure and Function","volume":"77","author":"McCord","year":"2020","journal-title":"Mol. Cell."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/thx.2006.070680","article-title":"Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension","volume":"62","author":"Suntharalingam","year":"2007","journal-title":"Thorax"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00408-014-9580-y","article-title":"BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension","volume":"192","author":"Feng","year":"2014","journal-title":"Lung"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000250322","article-title":"Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Relation to clinical parameters and comparison with left heart disease","volume":"79","author":"Ulrich","year":"2010","journal-title":"Respiration"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCRESAHA.107.148338","article-title":"Angiotensin-Converting Enzyme and Vascular Remodeling","volume":"101","author":"Heeneman","year":"2007","journal-title":"Circ. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1253\/circj.70.1174","article-title":"Angiotensin-Converting Enzyme Gene Polymorphisms and Prognosis in Chronic Thromboembolic Pulmonary Hypertension","volume":"70","author":"Tanabe","year":"2006","journal-title":"Circ. J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/674310","article-title":"MicroRNA Expression Profile of Pulmonary Artery Smooth Muscle Cells and the Effect of Let-7d in Chronic Thromboembolic Pulmonary Hypertension","volume":"3","author":"Wang","year":"2013","journal-title":"Pulm. Circ."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"900353","DOI":"10.3389\/fcvm.2022.900353","article-title":"Single-cell RNA-sequencing and microarray analyses to explore the pathological mechanisms of chronic thromboembolic pulmonary hypertension","volume":"9","author":"Miao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/ijmm.2013.1582","article-title":"Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension","volume":"33","author":"Gu","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Liley, J., Newnham, M., Bleda, M., Auger, W., Barbera, J.A., Bogaard, H., Delcroix, M., Fernandes, T.M., Howard, L., and Jenkins, D. (2023). CTEPH has shared and distinct genetic associations with pulmonary embolism in a genome-wide association study. medRxiv.","DOI":"10.1101\/2023.05.30.23290666"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ajhg.2015.01.019","article-title":"Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism","volume":"96","author":"Germain","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"ref_113","unstructured":"(2023, September 06). TSPAN15. The Human Protein Atlas. Available online: https:\/\/www.proteinatlas.org\/ENSG00000099282-TSPAN15."},{"key":"ref_114","unstructured":"(2023, September 06). TAP2. The Human Protein Atlas. Available online: https:\/\/www.proteinatlas.org\/ENSG00000204267-TAP2."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajhg.2012.05.009","article-title":"Genetic Associations for Activated Partial Thromboplastin Time and Prothrombin Time, their Gene Expression Profiles, and Risk of Coronary Artery Disease","volume":"91","author":"Tang","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1038\/s41467-020-17254-w","article-title":"The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function","volume":"11","author":"Bennett","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"100008","DOI":"10.1016\/j.chpulm.2023.100008","article-title":"Long-term Survival and Quality of Life: Results from the United States Chronic Thromboembolic Pulmonary Hypertension Registry","volume":"1","author":"Chin","year":"2023","journal-title":"CHEST Pulm."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.healun.2022.08.011","article-title":"Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension","volume":"42","author":"Wiedenroth","year":"2023","journal-title":"J. Heart Lung Transplant."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"ehaa946-2292","DOI":"10.1093\/ehjci\/ehaa946.2292","article-title":"Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era","volume":"41","author":"Taniguchi","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e004029","DOI":"10.1161\/CIRCOUTCOMES.117.004029","article-title":"Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension","volume":"10","author":"Ogawa","year":"2017","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ruaro, B., Confalonieri, P., Caforio, G., Baratella, E., Pozzan, R., Tavano, S., Bozzi, C., Lerda, S., Geri, P., and Biolo, M. (2022). Chronic Thromboembolic Pulmonary Hypertension: An Observational Study. Medicina, 58.","DOI":"10.3390\/medicina58081094"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"160107","DOI":"10.1183\/16000617.0107-2016","article-title":"Medical management of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Ghofrani","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.chest.2023.03.029","article-title":"Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension","volume":"164","author":"Yang","year":"2023","journal-title":"Chest"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e12110","DOI":"10.1002\/pul2.12110","article-title":"Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy","volume":"12","author":"Jeong","year":"2022","journal-title":"Pulm. Circ."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/jth.14649","article-title":"A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension","volume":"18","author":"Bunclark","year":"2020","journal-title":"J. Thromb. Haemost."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/1\/46\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:15Z","timestamp":1760132475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/1\/46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,24]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["biomedicines12010046"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12010046","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,24]]}}}